2,256
Views
42
CrossRef citations to date
0
Altmetric
Research Article

Niosomal encapsulation of ethambutol hydrochloride for increasing its efficacy and safety

, , , , &
Pages 21-36 | Received 04 Oct 2013, Accepted 19 Nov 2013, Published online: 20 Dec 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Pooneh Kia, Umme Ruman, Ariyati Retno Pratiwi & Mohd Zobir Hussein. (2023) Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis. International Journal of Nanomedicine 18, pages 1159-1191.
Read now
Mrunal Jadhav, Tabassum Khan, Chintan Bhavsar, Munira Momin & Abdelwahab Omri. (2019) Novel therapeutic approaches for targeting TB and HIV reservoirs prevailing in lungs. Expert Opinion on Drug Delivery 16:7, pages 687-699.
Read now
Muhammad Imran, Muhammad Raza Shah, Farhat Ullah, Shafi Ullah, Abdelbary M. A. Elhissi, Waqas Nawaz, Farid Ahmad, Abdul Sadiq & Imdad Ali. (2016) Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin. Drug Delivery 23:9, pages 3653-3664.
Read now
Shafi Ullah, Muhammad Raza Shah, Mohammad Shoaib, Muhammad Imran, Abdelbary M. A. Elhissi, Farid Ahmad, Imdad Ali & Syed Wadood Ali Shah. (2016) Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin. Drug Delivery 23:9, pages 3480-3491.
Read now
Sanaul Mustafa, Roopa S. Pai, Gurinder Singh & V. Kusum Devi. (2015) Nanocarrier-based interventions for the management of MDR/XDR-TB. Journal of Drug Targeting 23:4, pages 287-304.
Read now

Articles from other publishers (36)

Á. Santana-Garrido, M. Durán-Lobato, A. Mate, L. Martín-Banderas & C.M. Vázquez. (2024) Ophthalmic wild olive (ACEBUCHE) oil nanoemulsions exert oculoprotective effects against oxidative stress induced by arterial hypertension. International Journal of Pharmaceutics 649, pages 123602.
Crossref
Ayushi Nair, Alosh Greeny, Amritasree Nandan, Ranjay Kumar Sah, Anju Jose, Sathish Dyawanapelly, Vijayabhaskarreddy Junnuthula, Athira K. V.Prashant Sadanandan. (2023) Advanced drug delivery and therapeutic strategies for tuberculosis treatment. Journal of Nanobiotechnology 21:1.
Crossref
Mashudu T. Mphaphuli, Mduduzi N. Sithole, Pradeep Kumar, Pierre P.D. Kondiah, Mostafa Mabrouk & Yahya E. Choonara. (2023) Multi-purpose prototypes for extrapulmonary Mycobacterium tuberculosis targeting: A regenerative medicine perspective. Journal of Drug Delivery Science and Technology 89, pages 105039.
Crossref
Imdad Ali, Sana Rahim, Ahmad Awais, Muhammad Kawish, Remees Shuhsadh, Samiullah Burki, Ibrahim Javed, Muhammad Raza Shah, Muhammad Abdullah Shah, Hidayat Hussain & Riaz Ullah. (2023) Advancement in oral pharmacokinetics of an antibiotic Cefixime using amphiphilic 4-armed macrocyclic surfactant based niosomes. Arabian Journal of Chemistry 16:8, pages 104958.
Crossref
Horacio Bach & Ana C. Lorenzo‐Leal. (2023) Use of niosomes for the treatment of intracellular pathogens infecting the lungs. WIREs Nanomedicine and Nanobiotechnology 15:4.
Crossref
Geeta Patel, Bhupendra Prajapati & Yashwant Pathak. 2023. Tubercular Drug Delivery Systems. Tubercular Drug Delivery Systems 235 260 .
Mani Sharma & Sakshi Kansal. 2022. Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity. Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity 317 347 .
Kabi Raj Chaudhary, Vishal Puri, Arti Singh & Charan Singh. (2022) A review on recent advances in nanomedicines for the treatment of pulmonary tuberculosis. Journal of Drug Delivery Science and Technology 69, pages 103069.
Crossref
Filipa Santos & Ana Rita C. Duarte. 2022. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases 173 210 .
Pooja Sanjay Khairnar, Ajit Singh & Rahul Shukla. 2022. Nanotechnology for Infectious Diseases. Nanotechnology for Infectious Diseases 387 417 .
Priya Shrivastava, Laxmikant Gautam, Sonal Vyas & Suresh P. Vyas. 2022. Macrophage Targeted Delivery Systems. Macrophage Targeted Delivery Systems 379 398 .
Bashir A. Sheikh, Basharat A. Bhat, Bader Alshehri, Rakeeb A. Mir, Wajahat R. Mir, Zahoor A. Parry & Manzoor A. Mir. (2021) Nano-Drug Delivery Systems: Possible End to the Rising Threats of Tuberculosis. Journal of Biomedical Nanotechnology 17:12, pages 2298-2318.
Crossref
Ishwari ChoudharyPreeti K. Suresh. (2021) A Logical Approach to Development of Natamycin Loaded NLCs: Preformulation Studies, Formulation Development and In Vitro Characterization. Research Journal of Pharmacy and Technology, pages 6033-6040.
Crossref
Aristote B. Buya, Bwalya A. Witika, Alain M. Bapolisi, Chiluba Mwila, Grady K. Mukubwa, Patrick B. Memvanga, Pedzisai A. Makoni & Christian I. Nkanga. (2021) Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review. Pharmaceutics 13:12, pages 2041.
Crossref
Mohd Khairul Nizam Mazlan, Mohammad Hafizie Dianel Mohd Tazizi, Rosliza Ahmad, Muhammad Amirul Asyraf Noh, Athirah Bakhtiar, Habibah A. Wahab & Amirah Mohd Gazzali. (2021) Antituberculosis Targeted Drug Delivery as a Potential Future Treatment Approach. Antibiotics 10:8, pages 908.
Crossref
Goutam Rath, Deepak Pradhan, Goutam Ghosh & Amit K. Goyal. (2021) Challenges and Opportunities of Nanotechnological based Approach for the Treatment of Tuberculosis. Current Pharmaceutical Design 27:17, pages 2026-2040.
Crossref
Priya Shrivastava, Laxmikant Gautam, Anamika Jain, Nikhar Vishwakarma, Sonal Vyas & Suresh P. Vyas. 2021. Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer. Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer 87 113 .
Zsuzsa Baranyai, Héctor Soria‐Carrera, Maria Alleva, Ana C. Millán‐Placer, Ainhoa Lucía, Rafael Martín‐Rapún, José A. Aínsa & Jesús M. la Fuente. (2020) Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis. Advanced Therapeutics 4:1, pages 2000113.
Crossref
Xue Jin, Ling Song, Chao-Chao Ma, Yan-Chun Zhang & Shui Yu. (2020) RETRACTED: Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases. Saudi Pharmaceutical Journal 28:12, pages 1655-1665.
Crossref
Wei Chen, Lili Huang, Qiusha Tang, Shiwei Wang, Chunmei Hu & Xia Zhang. (2020) Progress on diagnosis and treatment of central nervous system tuberculosis. Radiology of Infectious Diseases 7:4, pages 160-169.
Crossref
Ali Ibrahim Bekraki. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment 107 122 .
Damián Eduardo Pérez-Martínez & Roberto Zenteno-Cuevas. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment 37 52 .
Josef Jampílek & Katarína Kráľová. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health 469 502 .
Prasad Minakshi, Mayukh Ghosh, Basanti Brar, Rajesh Kumar, Upendra P. Lambe, Koushlesh Ranjan, Jinu Manoj & Gaya Prasad. (2019) Nano-antimicrobials: A New Paradigm for Combating Mycobacterial Resistance. Current Pharmaceutical Design 25:13, pages 1554-1579.
Crossref
Shahinda S.R. Alsayed, Chau C. Beh, Neil R. Foster, Alan D. Payne, Yu Yu & Hendra Gunosewoyo. (2019) Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis. Current Molecular Pharmacology 12:1, pages 27-49.
Crossref
Kamal Dua, Vamshi Krishna Rapalli, Shakti Dhar Shukla, Gautam Singhvi, Madhur D. Shastri, Dinesh Kumar Chellappan, Saurabh Satija, Meenu Mehta, Monica Gulati, Terezinha De Jesus Andreoli Pinto, Gaurav Gupta & Philip M. Hansbro. (2018) Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches. Biomedicine & Pharmacotherapy 107, pages 1218-1229.
Crossref
Estefania Grotz, Nancy Tateosian, Nicolas Amiano, Maximiliano Cagel, Ezequiel Bernabeu, Diego A. Chiappetta & Marcela A. Moretton. (2018) Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead. Pharmaceutical Research 35:11.
Crossref
Lakhvir Kaur, Kanwaldeep Singh, Surinder Paul, Sukhprit Singh, Shashank Singh & Subheet Kumar Jain. (2018) A Mechanistic Study to Determine the Structural Similarities Between Artificial Membrane Strat-M™ and Biological Membranes and Its Application to Carry Out Skin Permeation Study of Amphotericin B Nanoformulations. AAPS PharmSciTech 19:4, pages 1606-1624.
Crossref
Rout George Kerry, Sushanto Gouda, Bikram Sil, Gitishree Das, Han-Seung Shin, Gajanan Ghodake & Jayanta Kumar Patra. (2018) Cure of tuberculosis using nanotechnology: An overview. Journal of Microbiology 56:5, pages 287-299.
Crossref
Kiran Patil, Shashikant Bagade, Smita Bonde, Sanjay Sharma & Gaurav Saraogi. (2018) Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities. Biomedicine & Pharmacotherapy 99, pages 735-745.
Crossref
Abbas Pardakhty. 2017. Pharmaceutical Sciences. Pharmaceutical Sciences 154 184 .
Abbas Pardakhty. 2017. Novel Approaches for Drug Delivery. Novel Approaches for Drug Delivery 89 119 .
Ahmed Alaa Kassem, Sameh Hosam Abd El-Alim & Marwa Hasanein Asfour. (2017) Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition. International Journal of Pharmaceutics 517:1-2, pages 256-268.
Crossref
Lalit Kumar, Shivani Verma, Bhuvaneshwar Vaidya & Neelesh K. Mehra. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy 293 324 .
Josef Jampílek & Katarína Král'ová. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy 23 54 .
Amit K. Goyal, Tarun Garg, Sourav Bhandari & Goutam Rath. 2017. Nanostructures for Drug Delivery. Nanostructures for Drug Delivery 669 695 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.